- Top 10 Shiba Inu whale inflows jump to 10.44 billion SHIB, active addresses up
- No layoffs, no new hires! U.S. initial jobless claims fall to lowest since July, September layoffs decrease by 18%
- Sources say SpaceX's AI division has negotiated with Microsoft to lease computing power.
- BUZZ-Capstone Energy shares rise on turbine order for Argentina natural gas compression facility
- BUZZ - Shares of National Energy Services Company rise, BMO initiates with "Outperform" rating
- Federal Reserve’s Collins says the labor market is near full employment but inflation is too high
- Everbright Digital names Guo Ming CEO, replacing Leung Chun Yip
- UBS Adjusts Price Target on Fomento Economico Mexicano to $130 From $139, Keeps Neutral Rating
- Euro: Outlook weakens as risks build – Rabobank
- McGraw Hill Prepays $50 Million Under Term Loan Facility
- Xenon Pharmaceuticals Insider Bought Shares Worth $1,121,400, According to a Recent SEC Filing
- Citi Expands Stablecoin Integration Into Traditional Financial Infrastructure
- PRECIOUS-Gold rises as softer inflation data dents Fed rate-hike bets
- Chicago Fed's real-time unemployment rate forecast for September is 4.10%
- AT&T, T-Mobile and Verizon Form JV to Eliminate 'Dead Zones'
- Octopus AIM VCT 2 estimates Sept. 28 NAV at 31.9 pence a share
- Octopus AIM VCT estimates NAV at 40.0 pence per share as of 28 September 2026
- LTC Properties declares monthly cash dividend of $0.19 per share for Q4 2026
- Xenon Pharma CEO Ian Mortimer acquires $1,121,400 in common shares
- Creatd Agrees To Acquire Remaining 90% Of C2 Live And Targets October 31, 2026 Closing >CRTD
- Sector Update: Financial Stocks Lean Lower Pre-Bell Thursday
- ZoomInfo Technologies Launches Agent Teams
- FOMENTO ECONOMICO MEXICANO SAB DE CV <FMX.N>: UBS CUTS TARGET PRICE TO $130 FROM $139
- Controlled Thermal Resources says $205 million of convertible debt converts to equity in Plum IV deal closing
- Sector Update: Healthcare Stocks Decline Premarket Thursday
- Sector Update: Consumer Stocks Advance Pre-Bell Thursday
- Gain Therapeutics plans Phase 2 trial of rexaceract in Parkinson's disease for Q1 2027 start
- Updated version 1 - Tesla's registrations across Europe increased in September, with recovery momentum continuing.
- The new Amazon Kindle Paperwhite starts at $199.99.
- Apimeds Pharmaceuticals appoints Eric Sherb as CFO effective Oct. 1
- BioCardia files revised FDA De Novo pre-submission for Helix catheter clearance
- LTC Properties buys three seniors housing communities for nearly $160 million
- Finning International Acquires John F Hunt Power Group to Expand its Power Rental Business in the UK
- Infosys Collaborates With Columbia University to Advance Enterprise AI Research
- Update: Market Chatter: UBS Pushes Back Against Shareholder Call to Leave Switzerland
- Minerals Technologies Launches $400 Million Private Offering
- Accenture Tops Fiscal Fourth-Quarter Views; Forecasts Annual Growth in Fiscal 2027
- ING says AI-driven TMT debt supply lifts long-dated corporate issuance by USD 55 billion in 2026
- BUZZ - After Accenture released its financial report, the IT consulting company led software stocks higher
- BUZZ - Stifel upgrades Hub Group to "Hold" as risk-reward profile improves
- Silchester International Investors cuts Andritz voting rights to 4.99% from 5.01%
- Amazon launches newly designed Kindle series products
- The number of Americans continuing to claim unemployment benefits has dropped to the lowest level since March 2023.
- KeyBank names Mike Keane COO of Key Wealth
- Magnum Ice Cream Could Raise Sales Guidance at 3Q Update -- Market Talk
- DoubleLine Income Solutions Fund declares USD 0.11 per share October distribution
- HEWLETT PACKARD ENTERPRISE COMPANY <HPE.N>: UBS RAISES TARGET PRICE TO $66 FROM $59
- ORMAT TECHNOLOGIES INC <ORA.N>: UBS CUTS TARGET PRICE TO $100 FROM $157
- ORMAT TECHNOLOGIES INC <ORA.N>: UBS CUTS TARGET PRICE TO $100 FROM $157
- DYNATRACE, INC <DT.N>: UBS RAISES TARGET PRICE TO $74 FROM $65
- WARNER MUSIC GROUP CORP. <WMG.O>: UBS RAISES TARGET PRICE TO $43 FROM $42
- BROOKFIELD RENEWABLE PARTNERS LP <BEP.N>: UBS CUTS TARGET PRICE TO $34 FROM $40
- FEMSA <FEMSAUBD.MX>: UBS CUTS TARGET PRICE TO MXN 235 FROM MXN 240
- ORCHESTRA BIOMED HOLDINGS INC <OBIO.O>: PIPER SANDLER RAISES TARGET PRICE TO $12 FROM $10
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Dimed announces R$ 0.1206394938 per share dividend for Q3 2026
- Achieve Life Sciences Names Benjamin Halladay CFO
- Sector Update: Energy
- Cybin Changes Legal Name to Helus Pharma
- Bulgaria Stock Exchange nine-month 2026 turnover rises 47.47% to EUR 648 million
- HDFC Bank Names Anup Bagchi CEO
- Vir Biotechnology Names Aziz Sawaf as CFO
- DoubleLine Yield Opportunities Fund declares October distribution of $0.1167 per share
- Sabre elects Rochelle Boas chief legal and administrative officer
- FingerMotion signs binding deal to acquire 20.2-acre Alberta site for AI inference compute campus
- Quebec Innovative Materials engages Earth Signal to process Nova Scotia seismic data
- Gallagher acquires New Zealand broker Albany Insurance Services
- --Danaos Raises Quarterly Dividend to $1 a Share From $0.90 a Share; Declares Special Dividend of $5 a Share, Both Payable Oct. 22 to Holders of Record on Oct. 13
- Chesapeake Utilities Launches $225 Million At-the-Market Share Offering Program
- FingerMotion And BlueFlare Sign Binding Agreement To Acquire 20-Acre Site In Hanna, Alberta, Establishing Hanna Campus #1 For AI Inference Compute >FNGR
- Sector Update: Financial
- AIM ImmunoTech says Phase 2 DURIPANC pancreatic cancer trial advances toward Q1 2027 topline data
- Outlook Therapeutics submits CMS application for permanent J-code for LYTENAVA
- NBT Bancorp updates financial calendar with third-quarter results release and conference call
- FedEx completes sale of FedEx Supply Chain to CMA CGM for $1.4 billion enterprise value
- Peruvian Metals Q3 processes 9,065 metric tonnes at Aguila Norte plant, down 4.5% yr/yr
- BUZZ-IT consulting firms lead software shares higher after Accenture results
- Bank of America Merrill Managed AUM tops $10 billion in PRS program
- La Rosa Holdings names Chairman Nicholas Adler CEO, interim CFO
- Airship AI wins USD 29 million DHS surveillance contracts
- Invesco schedules third-quarter 2026 results release and conference call
- First Community names AT&T South Carolina VP Terrance Ford to board
- Chemed updates financial calendar with upcoming quarterly earnings release and conference call
- Game Your Game CEO Soumya Das attends Maxim Growth Summit for investor meetings
- Choice Hotels CHRO Patrick Cimerola to step down at end-2026
- Applied Materials, Besi expand strategic partnership on next-generation advanced packaging for AI chips
- AT&T, T-Mobile, Verizon form joint venture to expand satellite-enabled mobile coverage in US dead zones
- Watts Water General Counsel Kenneth Lepage to retire in March 2027
- McKesson, CVS Health Extend Pharmaceutical Distribution Agreement
- Wave Life Sciences Says FDA Feedback Supports Registrational Pathway for WVE-006
- Watts Water: Lepage's Retirement Effective March 31, 2027 >WTS
- Arthur J Gallagher & Co Acquires New Zealand-based Albany Insurance for Undisclosed Terms >AJG
- Watts Water Has Started Search for Lepage's Successor >WTS
- Watts Water CCO, Chief Sustainability Officer Kenneth Lepage to Retire >WTS
- Arthur J. Gallagher & Co. Acquires Albany Insurance Services Limited >AJG
- La Rosa Holdings Acquired Latest-Generation NVIDIA B300 GPUs and Leased Those Assets Back Under a Long-Term Lease >LRHC
- Kyndryl Launches AI Innovation Lab in Dallas Area
